Nalaganje...
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Advances in the understanding of cancer immunotherapy and the development of multiple checkpoint inhibitors have dramatically changed the current landscape of cancer treatment. Recent large-scale phase III trials (e.g. PHOCUS, OPTiM) are establishing use of oncolytic viruses as another tool in the c...
Shranjeno v:
| izdano v: | Clin Transl Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234197/ https://ncbi.nlm.nih.gov/pubmed/30426287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0214-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|